Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: Role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits

被引:79
作者
Kashiwagi, K
Pahk, AJ
Masuko, T
Igarashi, K
Williams, K
机构
[1] UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104
[2] CHIBA UNIV,FAC PHARMACEUT SCI,INAGE KU,CHIBA 263,JAPAN
关键词
D O I
10.1124/mol.52.4.701
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
N-Methyl-D-aspartate (NMDA) receptors are modulated by extracellular spermine and protons and are blocked in a voltage-dependent manner by spermine and polyamine derivatives such as N-1-dansyl-spermine (N-1-DnsSpm). The effects of mutations in the first and third transmembrane domains (M1 and M3) and the pore-forming loop (M2) of NMDA receptor subunits were studied. Surprisingly, some mutations in M2 and M3 of the NR1 subunit, including mutations at W608 and N616 in M2, reduced spermine stimulation and proton inhibition. These mutations may have long-range allosteric effects or may change spermine-and pH-dependent gating processes rather than directly affecting the binding sites for these modulators because spermine stimulation and proton inhibition are not voltage dependent and are thought to involve binding sites outside the pore-forming regions of the receptor. A number of mutations in M1-M3, including mutations at tryptophan and tyrosine residues near the extracellular sides of M1 and M3, reduced block by spermine and N-1-DnsSpm. The effects of these mutants on channel block were characterized in detail by using N-1-DnsSpm, which produces block but not stimulation of NMDA receptors. Block by N-1-DnsSpm was studied by using voltage ramps analyzed with the Woodhull model of channel block. Mutations at W563 (in M1) and E621 (immediately after M2) in the NR1A subunit and at Y646 (in M3) and N616 (in the M2 loop) in the NR2B subunit reduced the affinity for N-1-DnsSpm without affecting the voltage dependence of block. These residues may form part of a binding site for N-1-DnsSpm. Mutation of a tryptophan residue at position W607 in the M2 region of NR2B greatly reduced block by N-1-DnsSpm, and N-1-DnsSpm could easily permeate channels containing this mutation. The results suggest that at least parts of the M1 and M3 segments contribute to the pore or vestibule of the NMDA channel and that a tryptophan in M2 (W607 in NR2B) may contribute to the narrow constriction of the pore.
引用
收藏
页码:701 / 713
页数:13
相关论文
共 44 条
  • [1] TOPOLOGY PROFILE FOR A GLUTAMATE-RECEPTOR - 3 TRANSMEMBRANE DOMAINS AND A CHANNEL-LINING REENTRANT MEMBRANE LOOP
    BENNETT, JA
    DINGLEDINE, R
    [J]. NEURON, 1995, 14 (02) : 373 - 384
  • [2] MULTIPLE EFFECTS OF SPERMINE ON N-METHYL-D-ASPARTIC ACID RECEPTOR RESPONSES OF RAT CULTURED HIPPOCAMPAL-NEURONS
    BENVENISTE, M
    MAYER, ML
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1993, 464 : 131 - 163
  • [3] CONTROL BY ASPARAGINE RESIDUES OF CALCIUM PERMEABILITY AND MAGNESIUM BLOCKADE IN THE NMDA RECEPTOR
    BURNASHEV, N
    SCHOEPFER, R
    MONYER, H
    RUPPERSBERG, JP
    GUNTHER, W
    SEEBURG, PH
    SAKMANN, B
    [J]. SCIENCE, 1992, 257 (5075) : 1415 - 1419
  • [4] N-1-dansyl-spermine and N-1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: Block and permeation of N-methyl-D-aspartate receptors
    Chao, J
    Seiler, N
    Renault, J
    Kashiwagi, K
    Masuko, T
    Igarashi, K
    Williams, K
    [J]. MOLECULAR PHARMACOLOGY, 1997, 51 (05) : 861 - 871
  • [5] CLONED GLUTAMATE RECEPTORS
    HOLLMANN, M
    HEINEMANN, S
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1994, 17 : 31 - 108
  • [6] N-GLYCOSYLATION SITE TAGGING SUGGESTS A 3-TRANSMEMBRANE DOMAIN TOPOLOGY FOR THE GLUTAMATE-RECEPTOR GLUR1
    HOLLMANN, M
    MARON, C
    HEINEMANN, S
    [J]. NEURON, 1994, 13 (06) : 1331 - 1343
  • [7] IGARASHI K, 1995, J PHARMACOL EXP THER, V272, P1101
  • [8] ISHII T, 1993, J BIOL CHEM, V268, P2836
  • [9] Spermidine-preferential uptake system in Escherichia coli - Identification of amino acids involved in polyamine binding in PotD protein
    Kashiwagi, K
    Pistocchi, R
    Shibuya, S
    Sugiyama, S
    Morikawa, K
    Igarashi, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12205 - 12208
  • [10] Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131